m⁶A Modulates RAN Translation From CAG Repeat Expansion RNA

Abstract

Nucleotide repeat expansions contribute to the development of a number of neurodegenerative diseases. Recent studies revealed that DNA sequences with CAG and other nucleotide repeat expansions can undergo bidirectional transcription, and the ensuing transcripts could be translated into proteins through repeat-associated non-AUG (RAN) translation; however, not much is known about the precise mechanisms underlying RAN translation. Here, we demonstrated that m⁶A, installed by METTL3 and removed by FTO, promotes RAN translation in all three reading frames from the expanded CAG repeat RNA derived from the human ATXN3 gene, in which repeat expansion contributes to spinocerebellar ataxia type 3 (SCA3). Genetic depletion and pharmacological inhibition of METTL3 result in significantly diminished levels of RAN translation products from all three reading frames, which could be restored by ectopic expression of wildtype METTL3, but not its catalytically inactive mutant. Conversely, genetic ablation of FTO led to augmented RAN translation in all three reading frames. Moreover, one of the RAN translation products, poly(serine), exhibits gel-like aggregates in cells. Together, our study unveiled a crucial role of m⁶A in modulating RAN translation from expanded CAG repeat RNA transcribed from the human ATXN3 gene, and documented new biophysical properties of the poly(serine) RAN translation product.

Keywords

CAG repeat expansion / N⁶-methyladenosine / RAN translation

References

[1] H. Y. Zoghbi and H. T. Orr, “Glutamine Repeats and Neurodegeneration,” Annual Review of Neuroscience 23 (2000): 217-247.

[2] H. S. McLoughlin, L. R. Moore, and H. L. Paulson, “Pathogenesis of SCA3 and Implications for Other Polyglutamine Diseases,” Neurobiology of Disease 134 (2020): 104635.

[3] A. Mykowska, K. Sobczak, M. Wojciechowska, P. Kozlowski, and W. J. Krzyzosiak, “CAG Repeats Mimic CUG Repeats in the Misregulation of Alternative Splicing,” Nucleic Acids Research 39 (2011): 8938-8951.

[4] S. J. Stochmanski, M. Therrien, J. Laganiere, et al., “Expanded ATXN3 Frameshifting Events Are Toxic in Drosophila and Mammalian Neuron Models,” Human Molecular Genetics 21 (2012): 2211-2218.

[5] T. Zu, B. Gibbens, N. S. Doty, et al., “Non-ATG-initiated Translation Directed by Microsatellite Expansions,” The Proceedings of the National Academy of Sciences 108 (2011): 260-265.

[6] M. Bañez-Coronel, F. Ayhan, A. D. Tarabochia, et al., “RAN Translation in Huntington Disease,” Neuron 88 (2015): 667-677.

[7] J. D. Cleary, A. Pattamatta, and L. P. W. Ranum, “Repeat-associated non-ATG (RAN) Translation,” Journal of Biological Chemistry 293 (2018): 16127-16141.

[8] S. Guo, L. Nguyen, and L. P. W. Ranum, “RAN Proteins in Neurodegenerative Disease: Repeating Themes and Unifying Therapeutic Strategies,” Current Opinion in Neurobiology 72 (2022): 160-170.

[9] W. Miao, L. Li, Y. Zhao, X. Dai, X. Chen, and Y. Wang, “HSP90 inhibitors Stimulate DNAJB4 Protein Expression Through a Mechanism Involving N6-Methyladenosine,” Nature Communications 10 (2019): 3613.

[10] J. Zhou, J. Wan, X. Gao, X. Zhang, S. R. Jaffrey, and S. B. Qian, “Dynamic M⁶A mRNA Methylation Directs Translational Control of Heat Shock Response,” Nature 526 (2015): 591-594.

[11] Y. Sun, H. Dai, X. Dai, et al., “m¹A in CAG Repeat RNA Binds to TDP-43 and Induces Neurodegeneration,” Nature 623 (2023): 580-587.

[12] J. Liu, Y. Yue, D. Han, et al., “A METTL3-METTL14 Complex Mediates Mammalian Nuclear RNA N6-Adenosine Methylation,” Nature Chemical Biology 10 (2014): 93-95.

[13] J. D. Cleary and L. P. W. Ranum, “Repeat-Associated Non-ATG (RAN) Translation in Neurological Disease,” Human Molecular Genetics 22 (2013): R45-R51.

[14] M. Jazurek-Ciesiolka, A. Ciesiolka, A. A. Komur, M. O. Urbanek-Trzeciak, W. J. Krzyzosiak, and A. Fiszer, “RAN Translation of the Expanded CAG Repeats in the SCA3 Disease Context,” Journal of Molecular Biology 432 (2020): 166699.

[15] E. Yankova, W. Blackaby, M. Albertella, et al., “Small-Molecule Inhibition of METTL3 as a Strategy Against Myeloid Leukaemia,” Nature 593 (2021): 597-601.

[16] G. Jia, Y. Fu, X. Zhao, et al., “N⁶-Methyladenosine in Nuclear RNA Is a Major Substrate of the Obesity-Associated FTO,” Nature Chemical Biology 7 (2011): 885-887.

[17] G. Zheng, J. A. Dahl, Y. Niu, et al., “ALKBH5 is a Mammalian RNA Demethylase That Impacts RNA Metabolism and Mouse Fertility,” Molecular Cell 49 (2013): 18-29.

[18] F. Ayhan, B. A. Perez, H. K. Shorrock, et al., “SCA8 RAN polySer Protein Preferentially Accumulates in White Matter Regions and Is Regulated by eIF3F,” Embo Journal 37 (2018): e99023.

[19] Y. Li, X. Dou, J. Liu, et al., “Globally Reduced N⁶-Methyladenosine (m⁶A) in C9ORF72-ALS/FTD Dysregulates RNA Metabolism and Contributes to Neurodegeneration,” Nature Neuroscience 26 (2023): 1328-1338.

[20] T. B. Nguyen, R. Miramontes, C. Chillon-Marinas, et al., “Aberrant Splicing in Huntington's Disease Accompanies Disrupted TDP-43 Activity and Altered M⁶A RNA Modification,” Nature Neuroscience 28 (2025): 280-292.

[21] G. Zhang, Y. Xu, X. Wang, et al., “Dynamic FMR1 Granule Phase Switch Instructed by M⁶A Modification Contributes to Maternal RNA Decay,” Nature Communications 13 (2022): 859.

[22] R. Owada, S. Mitsui, and K. Nakamura, “Exogenous Polyserine and Polyleucine Are Toxic to Recipient Cells,” Scientific Reports 12 (2022): 1685.

RIGHTS & PERMISSIONS

2025 The Author(s). Aggregate published by SCUT, AIEI, and John Wiley & Sons Australia, Ltd.